Sistemde güncelleme ve geliştirme çalışmaları devam etmektedir

The significance of a novel inflammatory biomarker, presepsin, in predicting disease prognosis in patients with COVID-19

KIRIKKALE UNIVERSITY Career
Staff Login Login

Publication

The significance of a novel inflammatory biomarker, presepsin, in predicting disease prognosis in patients with COVID-19

01 Ocak 2022 Makale Özgün Makale

Atıf kopyala

D. T. DEMİRCİ (2022). The significance of a novel inflammatory biomarker, presepsin, in predicting disease prognosis in patients with COVID-19. *European Review for Medical and Pharmacological Sciences*, 26(22), 8612–8619. https://doi.org/10.26355/eurrev_202211_30398

Yayın bilgileri

Dergi European Review for Medical and Pharmacological Sciences
Veri tabanı SCI-Expanded
Cilt / Sayı 26 / 22
Sayfa 8612 – 8619

Keywords

Dergi: European Review for Medical and Pharmacological Sciences | Yıl: 2022 | Cilt/Sayı: 26/22 | Sayfa: 8612-8619 | DOI: 10.26355/eurrev_202211_30398 | Yazarlar: Karacaer Cengiz,SERT HAVVA,DEMİRCİ TANER,VARIM CEYHUN,kaya gülsüm,genç ahmet bilal,ÇEKİÇ DENİZ,ERGENÇ HASAN,YAYLACI SELÇUK,NALBANT AHMET,KAYA TEZCAN,DEMİRCİ AYŞE,ÖZTOP KENAN EVREN | Anahtar kelimeler: The significance of a novel inflammatory biomarker, presepsin, in predicting disease prognosis in patients with COVID-19

UN Sustainable Development Goals

Goals linked to this publication

AI Assistant
Online